These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 12765440)

  • 1. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Barberà JA; Peinado VI; Santos S
    Eur Respir J; 2003 May; 21(5):892-905. PubMed ID: 12765440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA; Blanco I
    Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vasculature in COPD: The silent component.
    Blanco I; Piccari L; Barberà JA
    Respirology; 2016 Aug; 21(6):984-94. PubMed ID: 27028849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: recent advances in pathophysiology and management.
    Hida W; Tun Y; Kikuchi Y; Okabe S; Shirato K
    Respirology; 2002 Mar; 7(1):3-13. PubMed ID: 11896895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New pathophysiological concepts in pulmonary hypertension in COPD].
    Firă-Mladinescu O; Tudorache V; Mihăicuţă S; Cristescu A
    Pneumologia; 2003; 52(3-4):188-92. PubMed ID: 18210732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in COPD: old and new concepts.
    Barberà JA; Peinado VI; Santos S
    Monaldi Arch Chest Dis; 2000 Dec; 55(6):445-9. PubMed ID: 11272628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
    Zakynthinos E; Daniil Z; Papanikolaou J; Makris D
    Curr Drug Targets; 2011 Apr; 12(4):501-13. PubMed ID: 21194405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of exercise hypoxemia reflects pulmonary artery pressure during early exercise in chronic obstructive pulmonary disease patients.
    Miki K; Maekura R; Hiraga T; Hirotani A; Hashimoto H; Kitada S; Miki M; Yoshimura K; Naka N; Motone M
    Clin Physiol Funct Imaging; 2008 Jan; 28(1):64-9. PubMed ID: 18005165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated Perspectives on Pulmonary Hypertension in COPD.
    Blanco I; Tura-Ceide O; Peinado VI; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1315-1324. PubMed ID: 32606641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2010; 52(1):29-40. PubMed ID: 20364612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.
    Peinado VI; Gómez FP; Barberà JA; Roman A; Angels Montero M; Ramírez J; Roca J; Rodriguez-Roisin R
    J Heart Lung Transplant; 2013 Dec; 32(12):1262-9. PubMed ID: 24263025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe pulmonary hypertension and chronic obstructive pulmonary disease.
    Chaouat A; Bugnet AS; Kadaoui N; Schott R; Enache I; Ducoloné A; Ehrhart M; Kessler R; Weitzenblum E
    Am J Respir Crit Care Med; 2005 Jul; 172(2):189-94. PubMed ID: 15831842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension and cor pulmonale in COPD].
    Kuwahira I; Iwamoto T
    Nihon Rinsho; 2003 Dec; 61(12):2138-43. PubMed ID: 14674323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right heart function in COPD.
    Macnee W
    Semin Respir Crit Care Med; 2010 Jun; 31(3):295-312. PubMed ID: 20496299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E; Chaouat A; Kessler R
    Pneumonol Alergol Pol; 2013; 81(4):390-8. PubMed ID: 23744170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
    Wright JL; Levy RD; Churg A
    Thorax; 2005 Jul; 60(7):605-9. PubMed ID: 15994270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in COPD.
    Chaouat A; Naeije R; Weitzenblum E
    Eur Respir J; 2008 Nov; 32(5):1371-85. PubMed ID: 18978137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
    Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.